ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0384

A Tough Cell: The Argument for a Biomarker of Clinical and Imaging Outcomes in Spondyloarthritis: The Neutrophil Lymphocyte Ratio and the Platelet Lymphocyte Ratio

Rouhin Sen1, Emmeline Kim2, Elizabeth Cheng3, Kavya Ganuthula4, Meika Fang5, Gail Kerr6, Jessica Walsh7, Elizabeth Chang8, Siba Raychaudhuri9, Andreas Reimold10 and Liron Caplan11, 1University of Colorado School of Medicine/Rocky Mountain Regional Veterans Affairs Medical Center (VAMC), Denver, CO, 2University of Colorado School of Medicine, Aurora, CO, 3Rocky Mountain Regional VAMC, Aurora, CO, 4Rocky Mountain Regional VAMC/University of Colorado School of Medicine, Aurora, CO, 5David Geffen School of Medicine at UCLA/West Los Angeles Veterans Affairs Medical Center (VAMC), Los Angeles, CA, 6Washington D.C., Veterans Affairs Medical Center (VAMC)/Georgetown and Howard Universities, Washington, DC, 7Salt Lake City Veteran Affairs Medical Center (VAMC)/University of Utah Hospital, Salt Lake City, UT, 8Phoenix Veterans Affairs Medical Center (VAMC), Phoenix, AZ, 9Sacramento Veterans Affairs Medical Center (VAMC)/University of California-Davis Health, Davis, CA, 10University of Texas – Southwestern Medical Center/Dallas Veterans Affairs Medical Center (VAMC), Dallas, TX, 11Rocky Mountain Regional Veterans Affairs Medical Center (VAMC)/University of Colorado School of Medicine, Aurora, CO

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), Biomarkers, C-reactive protein (CRP), neutrophils, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Session Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Biomarkers of disease activity/severity and imaging outcomes in axial spondyloarthritis (axSpA) remain a challenge. The most common relevant biomarker is the C-Reactive Protein (CRP), but it is elevated in only 60% of clinically active axSpA patients and demonstrates low specificity. Several epidemiologic studies have identified the neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) as useful tools in the characterization of inflammatory disease. In this study, we explored the utility of the NLR and PLR in axSpA and their associations with patient reported outcomes (PROs), CRP and the erythrocyte sedimentation ratio (ESR), and sacroiliac joint (SIJ) radiograph damage scores.

Methods: The study population consisted of US veterans with a clinical diagnosis of axSpA enrolled in the Program to Understand Long-term Outcomes of Spondylarthritis (PULSAR) registry. Included data were sociodemographics, PROs, and pharmacologic variables. Absolute neutrophil, platelet, and lymphocyte counts were extracted from the VA Corporate Data Warehouse (CDW). To moderate the effect of medications on lab values, analyses were restricted to encounters in which patients were not taking disease modifying anti-rheumatic drugs. SIJ 3-view radiographs (Ferguson and obliques) were evaluated by three blinded readers using the scoring from the modified New York (mNY) criteria. Associations between NLR and PLR and the CRP, PROs (BASDAI and BASFI), and radiograph scores were calculated using linear regression and plotted with a superimposed regression line (including 95% CIs). Cell count data were used only if they were same day as clinical data (apart from radiographs within 90 days of labs). Statistical analysis was performed using STATA/MP v15 software.

Results: In the PULSAR registry, a majority were white males, HLAB27 positive, and reported current or former tobacco use (Table 1). Of 254 patients with a diagnosis of axSpA, the NLR and PLR were both associated the CRP with p < 0.001 (Figure 1). The CRP however, was not significantly associated with BASDAI or BASFI. In contrast, the ESR was the only inflammatory marker with significant associations to both BASDAI (p = 0.026) and BASFI (p < 0.001). The NLR had statistically significant correlation with BASFI (p = 0.038) while the PLR had statistically significant correlation with BASDAI (p = 0.028) (Table 2). There was no significant correlation between radiographic scores by mNY criteria and CRP, ESR, NLR, or PLR.

Conclusion: In our cohort, axSpA patients were found to have specific correlations between the NLR, PLR and PROs, suggesting additional parameters for disease assessment in clinical practice. Radiographs however did not correlate with selected laboratory data, perhaps reflecting poor correlation of accumulative damage with the transient nature of inflammatory, NLR and PLR indices. Additional variables in larger numbers of axSpA patients may provide further guidance of the utility of these biomarkers.


Disclosures: R. Sen, None; E. Kim, None; E. Cheng, None; K. Ganuthula, None; M. Fang, None; G. Kerr, Aurinia, 6, Novartis, 5, Bristol Myers Squibb, 1, 5, Pfizer, 1, Horizon, 1; J. Walsh, AbbVie, 2, 5, Merck, 2, 5, Pfizer, 2, 5, UCB, 2, 5, Eli Lilly, 1, 2, Novartis, 2, 5, Amgen, 2, 5; E. Chang, None; S. Raychaudhuri, Johnson & Johnson, 1, Abbvie, 5, 6, Sun Pharma, 5, UCB company, 1, Novartis, 1, Pfizer, 5; A. Reimold, None; L. Caplan, None.

To cite this abstract in AMA style:

Sen R, Kim E, Cheng E, Ganuthula K, Fang M, Kerr G, Walsh J, Chang E, Raychaudhuri S, Reimold A, Caplan L. A Tough Cell: The Argument for a Biomarker of Clinical and Imaging Outcomes in Spondyloarthritis: The Neutrophil Lymphocyte Ratio and the Platelet Lymphocyte Ratio [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-tough-cell-the-argument-for-a-biomarker-of-clinical-and-imaging-outcomes-in-spondyloarthritis-the-neutrophil-lymphocyte-ratio-and-the-platelet-lymphocyte-ratio/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-tough-cell-the-argument-for-a-biomarker-of-clinical-and-imaging-outcomes-in-spondyloarthritis-the-neutrophil-lymphocyte-ratio-and-the-platelet-lymphocyte-ratio/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences